You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

June 10, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Combo therapy yields intriguing results in melanoma progression

The results of a new study on a combination of drugs to treat melanoma, presented at the American Society of Clinical Oncology meeting in Chicago, are “unprecedented.”
» Study details

Continued advances in cancer outcomes unveiled at ASCO

Leading cancer drugs reduced the risk of death by half for people with lung cancer and assisted patients with HER2-positive breast cancer live longer without the disease recurring. » Findings presented at ASCO

Continuing Education

MTM essentials for COPD management: Part 1

This month’s CE activity is part of a CPE series, Medication Therapy Management for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month’s activity is to assist pharmacists in understanding the pathophysiology and pharmacologic treatment of COPD and to discuss how COPD is similar to and different from other chronic respiratory disorders.

To read and print the article with TEST questions, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT30-PYJ23.


Announcement: The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. To review your registration page or to register, go to: https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Move over Sovaldi: Could PCSK9 inhibitors be a bigger cost challenge?

The introduction of high-cost, high-use PCSK9 inhibitors (proproteinconvertasesubtilisin/kexin 9) enzyme inhibitors to treat high cholesterol could take the industry a step closer to a future where “healthcare costs break the bank,” according to industry insiders. » Read More

 

RELATED ARTICLES

Faster FDA approvals lead to cancer drug boom

Breast cancer drug research roundup from ASCO

RESOURCES

Latest Clinical News

Powered by Modern Medicine UBM  logo

UBM MEDICA